NORMODYNE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Normodyne, and when can generic versions of Normodyne launch?
Normodyne is a drug marketed by Schering and is included in two NDAs.
The generic ingredient in NORMODYNE is labetalol hydrochloride. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the labetalol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Normodyne
A generic version of NORMODYNE was approved as labetalol hydrochloride by HERITAGE PHARMA on August 3rd, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORMODYNE?
- What are the global sales for NORMODYNE?
- What is Average Wholesale Price for NORMODYNE?
Summary for NORMODYNE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 2 |
Patent Applications: | 4,247 |
DailyMed Link: | NORMODYNE at DailyMed |
Recent Clinical Trials for NORMODYNE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nebraska Methodist Health System | Phase 4 |
TriHealth Inc. | Phase 4 |
University of Kansas Medical Center | Phase 4 |
US Patents and Regulatory Information for NORMODYNE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | NORMODYNE | labetalol hydrochloride | INJECTABLE;INJECTION | 018686-001 | Aug 1, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Schering | NORMODYNE | labetalol hydrochloride | TABLET;ORAL | 018687-003 | Aug 1, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Schering | NORMODYNE | labetalol hydrochloride | TABLET;ORAL | 018687-001 | Aug 31, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORMODYNE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | NORMODYNE | labetalol hydrochloride | INJECTABLE;INJECTION | 018686-001 | Aug 1, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Schering | NORMODYNE | labetalol hydrochloride | TABLET;ORAL | 018687-001 | Aug 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Schering | NORMODYNE | labetalol hydrochloride | TABLET;ORAL | 018687-001 | Aug 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NORMODYNE
See the table below for patents covering NORMODYNE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Czechoslovakia | 167874 | ⤷ Sign Up | |
Netherlands | 6713016 | ⤷ Sign Up | |
Malaysia | 7400003 | PHENYLAMINOETHANOL DERIVATIVES | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |